Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sibutramine in Thai Obese and Overweight Subjects
NCT00234988Phase 4Completed
- Sponsor
- Abbott Laboratories
- Start
- Jun 2004
- Primary completion
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sibutramine in obesity, sponsored by Abbott Laboratories. Primary endpoints: Weight loss at 48 weeks and Safety parameters at 48 weeks. Started Jun 2004; status: completed.
02
Drugs
sibutramine
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00234988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00234988.